COVID-19 Yorkshire Rehabilitation Scale
A digital assessment and monitoring tool to help remotely manage individuals with persistent COVID symptoms. A not for profit initiative for all NHS organisations.
- Recommended by NHS England
- Funded by the NIHR
- Developed with NHS Trusts
- Used by the NHS across the UK
- Clinical validated for Long Covid patients
- Independently validated for assurance on clinical safety and information governance
- Contains other established outcome measures
For more information contact: c19-yrs@elaros.com
As Featured on BBC North West and ITV News Online
BBC North West recently featured the C19-YRS app on the 3rd September 2021 as part of an early implementation case study demonstrating its successful rollout at the Northern Care Alliance NHS Group.
The full news story can be read online on ITV News here.
Recommended by NHS England
NHS England has recommended routine use of C19-YRS at first assessment, 6 weeks and 6 months to monitor Long COVID in their National Guidance published in December 2020 and April 2021. The tool has also been recognised by NICE in their rapid guidelines for managing the long-term effects of COVID-19.
Created by clinical academics, supported by the NIHR
C19-YRS is a clinically validated outcome measure developed by clinical academics at The University of Leeds during the first wave of the pandemic. Its ongoing development and optimisation for delivery has been funded by the National Institute for Health Research.
Developed with NHS Trusts
Developed by clinicians across Leeds, Hull, and Airedale, with support from clinicians around the UK.
Supported by our first adopters in Salford Royal, Pennine Acute, and Liverpool University Hospitals NHS Trusts.
Enhanced by UK industry experts
Digitally enhanced by ELAROS 24/7 Ltd, building on their established CE-marked medical device, the Digital Bladder Diary platform. This project has been supported by Innovate UK.
Validation for clinical assurance
The digital C19-YRS has been independently validated by ORCHA as being compliant with national standards for usability, clinical safety, and information governance.
ELAROS has also met all standards for the NHS DSPT and obtained the CyberEssentials certification, demonstrating good practice in data security and protection.
Our Supporters
The digital C19-YRS has been developed by UK-based digital health company, ELAROS 24/7 Ltd, working closely with clinical researchers at The University of Leeds who developed the original self-report and provided initial funding to initiate the digital development with ELAROS’ third-party strategic partner software development company, Pipe & Piper in order to rapidly develop the platform to an industrial, clinically safe and secure standard. The scale was developed by clinicians at Leeds Teaching Hospitals Trust, Leeds Community Healthcare NHS Trust, and Airedale and Hull NHS Trusts.
It has been recommended for routine use by NHS England, funded by the NIHR, recognised by NICE, published in the ACNR, and endorsed by the British Society for Rehabilitation Medicine.
Benefits
For clinicians
- Multiple patients managed in one place
- Helps capture symptoms and guide rehabilitation interventions for patients
- Digitally enhanced integrated care
- Clear clinical audit trail
- Supports reporting to NHS Improvement
- Powerful reporting and research tools
- Long term capture and analysis
- Access to updates from world-leading long COVID researchers
- Free lifetime updates to the app and portal
For patients
- Access to the only validated tool designed for long Covid
- More reliable than a paper diary
- Automated data capture and assessment
- Completed anywhere, any time
- Digitally enhanced personalised care
- Completed alone or together with a carer or a HCP via telephone
- More informed rehabilitation interventions, potentially leading to better patient outcomes
- Sustainable remote patient monitoring
For research
- A research version of the platform is available
- Large scale remote data collection to drive research
- Supports clinics to conduct internal service evaluation
- Advanced vital research on post-COVID syndrome
- Development of a robust psychometric assessment of long COVID